APA (7th ed.) Citation

Mancia, G., Kjeldsen, S. E., Kreutz, R., Pathak, A., Grassi, G., & Esler, M. (2022). Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension (0194911X), 79(6), 1153. https://doi.org/10.1161/HYPERTENSIONAHA.122.19020

Chicago Style (17th ed.) Citation

Mancia, Giuseppe, Sverre E. Kjeldsen, Reinhold Kreutz, Atul Pathak, Guido Grassi, and Murray Esler. "Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines." Hypertension (0194911X) 79, no. 6 (2022): 1153. https://doi.org/10.1161/HYPERTENSIONAHA.122.19020.

MLA (9th ed.) Citation

Mancia, Giuseppe, et al. "Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines." Hypertension (0194911X), vol. 79, no. 6, 2022, p. 1153, https://doi.org/10.1161/HYPERTENSIONAHA.122.19020.